QV Bioelectronics gets £2m boost for brain tumour treatment

Manchester-based medical device startup raises £2M to extend lives of patients with brain tumours — TFN

QV Bioelectronics, a medtech company based in Cheshire, has raised £2 million in a pre-Series A funding round. The company is developing GRACE, an implanted medical device that uses electric field therapy to treat brain tumors. The funding will be used to expand pre-clinical studies and determine the device's safety. The round was led by Fink Family Office and Science Angel Syndicate, with participation from Northern Gritstone, Elbow Beach Capital, SOSV, and Catapult Ventures.

QV Bioelectronics Raises £2 Million to Advance Brain Tumor Treatment Technology

QV Bioelectronics is a Cheshire-based medtech company developing GRACE, a first-of-its-kind implanted medical device for brain tumor treatment. GRACE utilizes electric field therapy (EFT) to target dividing cancer cells in the brain while avoiding healthy cells.

QV Bioelectronics is developing GRACE, a first-of-its-kind implanted medical device for brain tumor treatment using electric field therapy.

3 years ago

QV Bioelectronics Raises £2 Million to Advance Brain Tumor Treatment Technology

ProblemHealthcare

Solution

Covered on